Der var ingen tegn på, at de påviste antistoffer repræsenterede et specifikt immunrespons til drotrecogin alfa (aktiveret) - behandling.
There was no evidence that the antibodies detected represented a specific immune response to drotrecogin alfa (activated) therapy.